Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

SBC Medical Group Holdings Incorporated (SBC) had Cost of Goods Sold of $49.37M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$205.42M
Net Income	$46.61M
Cost of Goods Sold	$49.37M
Gross Profit	$156.05M
Operating Expenses	$135.11M
Operating Income	$70.30M
Non-Operating Income/Expense	$3.15M
Pre-Tax Income	$73.46M
Normalized Pre-Tax Income	$73.46M
Income after Taxes	$46.69M
Income from Continuous Operations	$46.69M
Consolidated Net Income/Loss	$46.69M
Normalized Income after Taxes	$46.69M
EBIT	$70.30M
EBITDA	$74.10M
Weighted-Average Shares Outstanding (Basic)	96.56M
Weighted-Average Shares Outstanding (Diluted)	96.56M
Earnings per Share (EPS) (Basic)	$0.48
Earnings per Share (EPS) (Diluted)	$0.48
Balance Sheet Financials
Current Assets	$184.45M
Property, Plant, and Equipment	$8.77M
Long-Term Assets	$81.63M
Total Assets	$266.08M
Current Liabilities	$61.19M
Long-Term Debt	$6.51M
Long-Term Liabilities	$9.87M
Total Liabilities	$71.06M
Common Equity	$195.02M
Tangible Shareholders Equity	$188.82M
Shareholders Equity	$195.02M
Common Shares Outstanding	102.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$20.58M
Cash Flow from Investing Activities	$-10.10M
Cash Flow from Financial Activities	$22.97M
Beginning Cash	$103.02M
End Cash	$125.04M
Increase/Decrease in Cash	$22.02M
Stock-Based Compensation	$13.02M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.01
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.04
Gross Margin	75.97%
Operating Margin	34.23%
EBIT Margin	34.23%
EBITDA Margin	36.07%
Pre-Tax Profit Margin	35.76%
Profit Margin	22.69%
Free Cash Flow	$17.17M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.77
Inventory Turnover	33.02
Receiveable Turnover	5.05
Days Sales in Receivables	72.22
Return on Equity	23.94%
Return on Tangible Equity	24.73%
Return on Assets	17.55%
Return on Investments	23.17%
Book Value Per Share	$1.90
Free Cash Flow per Share	$0.18
Operating Cash Flow per Share	$0.21

Data from Zacks Investment Research, Inc.